Clinical trial
Tumor RNA Transfected Dendritic Cell Vaccines
NCT00108264 · US Department of Veterans Affairs, U.S. Fed · Completed
Key facts
| NCT number | NCT00108264 |
|---|---|
| Title | Tumor RNA Transfected Dendritic Cell Vaccines |
| Official title | Tumor RNA Transfected Dendritic Cell Vaccines |
| Lead sponsor | US Department of Veterans Affairs, U.S. Fed |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Prostate Cancer |
| Intervention type | Biological |
| Interventions | Tumor RNA transfected dendritic cells |
| Completion | Sep 1, 2005 |
| First posted | Apr 15, 2005 |
| Last update posted | Jan 21, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: